141 related articles for article (PubMed ID: 38679728)
1. HBB as a Novel Biomarker for the Diagnosis and Monitoring of Lung Cancer Regulates Cell Proliferation via ERK1/2 Pathway.
Xu X; Cai H; Peng J; Liu H; Chu F
Technol Cancer Res Treat; 2024; 23():15330338241249032. PubMed ID: 38679728
[No Abstract] [Full Text] [Related]
2. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
Tong L; Wu W
Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
[TBL] [Abstract][Full Text] [Related]
3. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
Su WZ; Ren LF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
[TBL] [Abstract][Full Text] [Related]
7. Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer.
Tang H; Zhao L; Li M; Li T; Hao Y
J Cell Biochem; 2019 Apr; 120(4):5055-5061. PubMed ID: 30320899
[TBL] [Abstract][Full Text] [Related]
8. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
[TBL] [Abstract][Full Text] [Related]
9. Correlations of hsa_circ_0046264 expression with onset, pathological stage and chemotherapy resistance of lung cancer.
Liu ZH; Yang SZ; Chen XT; Shao MR; Dong SY; Zhou SY; Liu L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9511-9521. PubMed ID: 33015793
[TBL] [Abstract][Full Text] [Related]
10. Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
Ge Q; Cong P; Ji Y
IUBMB Life; 2019 Nov; 71(11):1806-1814. PubMed ID: 31419016
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-144 regulates proliferation, invasion, and apoptosis of cells in malignant solitary pulmonary nodule via zinc finger E-box-binding homeobox 1.
Zhang G; An H; Fang X
Int J Clin Exp Pathol; 2015; 8(5):5960-7. PubMed ID: 26191328
[TBL] [Abstract][Full Text] [Related]
12. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
13. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of microRNA let-7a expression for efficacy and prognosis of radiotherapy in patients with lung cancer brain metastasis: A case-control study.
Liu JK; Liu HF; Ding Y; Gao GD
Medicine (Baltimore); 2018 Nov; 97(44):e12847. PubMed ID: 30383637
[TBL] [Abstract][Full Text] [Related]
15. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
16. Expression level of long noncoding RNA H19 in plasma of patients with nonsmall cell lung cancer and its clinical significance.
Luo J; Li Q; Pan J; Li L; Fang L; Zhang Y
J Cancer Res Ther; 2018; 14(4):860-863. PubMed ID: 29970666
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
18. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA SNHG4 Is a Potential Diagnostic and Prognostic Indicator in Non-Small Cell Lung Cancer.
Li Z; Zhuo Y; Li J; Zhang M; Wang R; Lin L
Ann Clin Lab Sci; 2021 Sep; 51(5):654-662. PubMed ID: 34686507
[TBL] [Abstract][Full Text] [Related]
20. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
Zhang T; Chu L; Tan W; Ye C; Dong H
Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]